Welcure Drugs & Pharmaceuticals share news and announcements

BSE: 524661Pharmaceuticals & BiotechnologySmall Cap

₹0.18₹0.02 (10.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.20.

52-week range of traded prices to 23 Oct 2026

₹0.17Low, 23 Oct 2026₹0.72High, 23 Oct 2025

Market cap: ₹22 Cr3,646th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 76,25,873

Welcure Drugs & Pharmaceuticals routine notices

125 filed, newest first. Page 2 of 3.

Jun 2023
- 30 Jun · Routine
  With reference to circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and SEBI (PIT) Regulations, 2015 read with the provisions of the Company for all the Designated Persons (as defined .... (opens in a new tab)
- 3 Jun · Routine
  I have examined: a) all the documents and records made available to us and explanation provided by Welcure Drugs & Pharmaceuticals Ltd ('the listed entity'), b) the filings/ submissions .... (opens in a new tab)
May 2023
- 29 May · Routine
  In pursuant to SEBI Circular No CIR/CFD/CMD 1/27/2019 dated February 08, 2019 and Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, we are attaching .... (opens in a new tab)
- 23 May · Routine
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve With reference .... (opens in a new tab)
- 13 May · Routine
  In compliance with Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and based on the intimation received .... (opens in a new tab)
Apr 2023
- 15 Apr · Routine
  With reference to circular No. SEBI/ HO/DDHS/CIR/P 2018/144 DATED 26TH NOVEMBER, 2018 in respect of fund raising by issuance of Debt securities by Large Securities, we hereby confirm that .... (opens in a new tab)
- 10 Apr · Routine
  We are hereby submitting the Certificate under Regulation 74(5) of the SEBI (Depository & Participant) Regulations, 2018 for the quarter and year ended 31st March, 2023. (opens in a new tab)
Mar 2023
- 31 Mar · Routine
  With reference to circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the provisions of the Company's Insider Trading .... (opens in a new tab)
Feb 2023
- 16 Feb · Routine
  In continuation to our letter dated 14th February, 2023, regarding approval of Un-Audited Financial Results for Quarter ended 31st December, 2022; please find enclosed, the newspaper advertisement .... (opens in a new tab)
- 1 Feb · Routine
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve With reference .... (opens in a new tab)
Jan 2023
- 11 Jan · Routine
  Dear Sir, We are hereby submitting the Certificate under Regulation 74(5) of the SEBI (Depository & Participant) Regulations, 2018 for the quarter ended 31st December, 2022. Please find .... (opens in a new tab)
Dec 2022
- 31 Dec · Routine
  With reference to circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the provisions of the Company's Insider Trading .... (opens in a new tab)
Nov 2022
- 2 Nov · Routine
  Intimation under Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
Oct 2022
- 10 Oct · Routine
  In continuation to our letter dated 08th October, 2022, regarding approval of Un-Audited Financial Results for Quarter and half year ended 30th September, 2022; please find enclosed the .... (opens in a new tab)
- 3 Oct · Routine
  Certificate received from .... (opens in a new tab)
Sep 2022
- 30 Sep · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
- 29 Sep · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Aug 2022
- 17 Aug · Routine
  Intimation for Loss of Original Share Certificates (opens in a new tab)
Jul 2022
- 18 Jul · Routine
  In continuation to our letter dated 16th July, 2022, regarding approval of Un-audited Financial Results for Quarter ended 30th June, 2022; please find enclosed the newspaper advertisement .... (opens in a new tab)
- 6 Jul · Routine
  Certificate received from .... (opens in a new tab)
Jun 2022
- 27 Jun · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
May 2022
- 28 May · Routine
  In terms of General circular dated 5th May, 2020 read with circulars dated 8th April, 2020, 13th April, 2020, 15th June, 2020, 28th September, 2020, 31st December, 2020, 13th January, 2021, .... (opens in a new tab)
- 2 May · Routine
  Please find the enclosed the scanned copy of the Annual Secretarial Compliance .... (opens in a new tab)
Apr 2022
- 16 Apr · Routine
  In continuation to our letter dated 15th February, 2022, regarding approval of Audited Financial Results for quarter and year ended 31st March, 2022; please find enclosed the newspaper .... (opens in a new tab)
- 8 Apr · Routine
  Certificate received from .... (opens in a new tab)
- 4 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 1 Apr · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Mar 2022
- 31 Mar · Routine
  Intimation for Loss of Original Share Certificates (opens in a new tab)
Jan 2022
- 24 Jan · Routine
  In continuation to our letter dated 22 January, 2022, regarding approval of Un-Audited Financial Results for quarter and nine months ended 31 December, 2022; please find enclosed the newspaper .... (opens in a new tab)
- 13 Jan · Routine
  Certificate received from .... (opens in a new tab)
Dec 2021
- 27 Dec · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Oct 2021
- 26 Oct · Routine
  In continuation to our letter dated 25th October, 2021, regarding approval of Un-audited Financial Results for quarter and half year ended 30th September, 2021; please find enclosed the .... (opens in a new tab)
- 14 Oct · Routine
  Certificate received from .... (opens in a new tab)
Sep 2021
- 24 Sep · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Jul 2021
- 13 Jul · Routine
  In continuation to our letter dated 12th July, 2021, regarding approval of Un-audited Financial Results for Quarter ended 30th June, 2021; please find enclosed the newspaper advertisement .... (opens in a new tab)
- 5 Jul · Routine
  Certificate received from .... (opens in a new tab)
Jun 2021
- 25 Jun · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
May 2021
- 26 May · Routine
  In terms of General Circular no. 02/2021 dated January 13, 2021 in continuation of General Circular No. 14/2020 dated April 08, 2020, Circular No.17/2020 dated April 13, 2020 and Circular .... (opens in a new tab)
- 14 May · Routine
  Please find the enclosed the scanned copy of the Annual Secretarial Compliance .... (opens in a new tab)
Apr 2021
- 27 Apr · Routine
  In continuation to our letter dated 26th April, 2021, regarding approval of Audited Financial Results for Quarter & year ended 31st March, 2021; please find enclosed the newspaper advertisement .... (opens in a new tab)
- 13 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 6 Apr · Routine
  Certificate received from .... (opens in a new tab)
Mar 2021
- 25 Mar · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Jan 2021
- 18 Jan · Routine
  In continuation to our letter dated 16th January, 2021, regarding approval of Un-audited Financial Results for Quarter & Nine months ended 31st December, 2020; please find enclosed the .... (opens in a new tab)
- 6 Jan · Routine
  Certificate received from .... (opens in a new tab)
Dec 2020
- 30 Dec · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Oct 2020
- 17 Oct · Routine
  In continuation to our letter dated 16th October, 2020, regarding approval of Un-audited Financial Results for Quarter & half year ended 30th September, 2020; please find enclosed the newspaper .... (opens in a new tab)
- 13 Oct · Routine
  Certificate received from .... (opens in a new tab)
Sep 2020
- 25 Sep · Routine
  Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from .... (opens in a new tab)
Jul 2020
- 31 Jul · Routine
  Please find the enclosed the scanned copy of the Annual Secretarial Compliance .... (opens in a new tab)

Welcure Drugs & Pharmaceuticals routine notices

Jun 2023

May 2023

Apr 2023

Mar 2023

Feb 2023

Jan 2023

Dec 2022

Nov 2022

Oct 2022

Sep 2022

Aug 2022

Jul 2022

Jun 2022

May 2022

Apr 2022

Mar 2022

Jan 2022

Dec 2021

Oct 2021

Sep 2021

Jul 2021

Jun 2021

May 2021

Apr 2021

Mar 2021

Jan 2021

Dec 2020

Oct 2020

Sep 2020

Jul 2020